vs
Side-by-side financial comparison of GSI TECHNOLOGY INC (GSIT) and Sensus Healthcare, Inc. (SRTS). Click either name above to swap in a different company.
GSI TECHNOLOGY INC is the larger business by last-quarter revenue ($6.1M vs $4.9M, roughly 1.2× Sensus Healthcare, Inc.). GSI TECHNOLOGY INC runs the higher net margin — -49.7% vs -64.1%, a 14.4% gap on every dollar of revenue. On growth, GSI TECHNOLOGY INC posted the faster year-over-year revenue change (12.2% vs -62.2%). Sensus Healthcare, Inc. produced more free cash flow last quarter ($-2.4M vs $-8.2M). Over the past eight quarters, GSI TECHNOLOGY INC's revenue compounded faster (8.6% CAGR vs -31.9%).
Triad GSI is an American voting machine vendor based in Xenia, Ohio. Their main products are election-related computer hardware and software for counting ballots, as well as voter registration.
Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.
GSIT vs SRTS — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $6.1M | $4.9M |
| Net Profit | $-3.0M | $-3.2M |
| Gross Margin | 52.7% | 38.4% |
| Operating Margin | -113.7% | -63.8% |
| Net Margin | -49.7% | -64.1% |
| Revenue YoY | 12.2% | -62.2% |
| Net Profit YoY | 25.0% | -304.9% |
| EPS (diluted) | $-0.09 | $-0.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $6.1M | $4.9M | ||
| Q3 25 | $6.4M | $6.9M | ||
| Q2 25 | $6.3M | $7.3M | ||
| Q1 25 | $5.9M | $8.3M | ||
| Q4 24 | $5.4M | $13.1M | ||
| Q3 24 | $4.5M | $8.8M | ||
| Q2 24 | $4.7M | $9.2M | ||
| Q1 24 | $5.2M | $10.7M |
| Q4 25 | $-3.0M | $-3.2M | ||
| Q3 25 | $-3.2M | $-943.0K | ||
| Q2 25 | $-2.2M | $-1.0M | ||
| Q1 25 | $-2.2M | $-2.6M | ||
| Q4 24 | $-4.0M | $1.5M | ||
| Q3 24 | $-5.5M | $1.2M | ||
| Q2 24 | $1.1M | $1.6M | ||
| Q1 24 | $-4.3M | $2.3M |
| Q4 25 | 52.7% | 38.4% | ||
| Q3 25 | 54.8% | 39.4% | ||
| Q2 25 | 58.1% | 39.7% | ||
| Q1 25 | 56.1% | 52.2% | ||
| Q4 24 | 54.0% | 54.4% | ||
| Q3 24 | 38.6% | 59.3% | ||
| Q2 24 | 46.3% | 58.7% | ||
| Q1 24 | 51.6% | 62.5% |
| Q4 25 | -113.7% | -63.8% | ||
| Q3 25 | -49.5% | -37.3% | ||
| Q2 25 | -34.6% | -26.6% | ||
| Q1 25 | -38.7% | -31.7% | ||
| Q4 24 | -74.9% | 13.2% | ||
| Q3 24 | -122.7% | 16.9% | ||
| Q2 24 | 23.1% | 21.5% | ||
| Q1 24 | -87.6% | 27.1% |
| Q4 25 | -49.7% | -64.1% | ||
| Q3 25 | -49.4% | -13.7% | ||
| Q2 25 | -35.3% | -14.2% | ||
| Q1 25 | -37.9% | -30.8% | ||
| Q4 24 | -74.4% | 11.8% | ||
| Q3 24 | -120.0% | 13.7% | ||
| Q2 24 | 23.1% | 17.4% | ||
| Q1 24 | -83.9% | 21.3% |
| Q4 25 | $-0.09 | $-0.19 | ||
| Q3 25 | $-0.11 | $-0.06 | ||
| Q2 25 | $-0.08 | $-0.06 | ||
| Q1 25 | $-0.09 | $-0.16 | ||
| Q4 24 | $-0.16 | $0.10 | ||
| Q3 24 | $-0.21 | $0.07 | ||
| Q2 24 | $0.04 | $0.10 | ||
| Q1 24 | $-0.17 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $70.7M | $22.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $83.6M | $48.1M |
| Total Assets | $98.5M | $53.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.7M | $22.1M | ||
| Q3 25 | $25.3M | $24.5M | ||
| Q2 25 | $22.7M | $22.2M | ||
| Q1 25 | $13.4M | $19.1M | ||
| Q4 24 | $15.1M | $22.1M | ||
| Q3 24 | $18.4M | $22.6M | ||
| Q2 24 | $21.8M | $19.0M | ||
| Q1 24 | $14.4M | $14.7M |
| Q4 25 | $83.6M | $48.1M | ||
| Q3 25 | $38.6M | $51.2M | ||
| Q2 25 | $37.4M | $52.1M | ||
| Q1 25 | $28.2M | $53.0M | ||
| Q4 24 | $29.9M | $55.8M | ||
| Q3 24 | $33.3M | $54.1M | ||
| Q2 24 | $38.0M | $52.9M | ||
| Q1 24 | $36.0M | $51.2M |
| Q4 25 | $98.5M | $53.0M | ||
| Q3 25 | $52.0M | $58.3M | ||
| Q2 25 | $50.5M | $58.9M | ||
| Q1 25 | $43.3M | $60.2M | ||
| Q4 24 | $44.1M | $62.2M | ||
| Q3 24 | $47.4M | $59.9M | ||
| Q2 24 | $52.3M | $58.2M | ||
| Q1 24 | $42.5M | $57.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-7.9M | $-2.2M |
| Free Cash FlowOCF − Capex | $-8.2M | $-2.4M |
| FCF MarginFCF / Revenue | -134.4% | -47.9% |
| Capex IntensityCapex / Revenue | 4.9% | 3.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-12.5M | $332.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-7.9M | $-2.2M | ||
| Q3 25 | $-887.0K | $2.3M | ||
| Q2 25 | $-1.7M | $3.1M | ||
| Q1 25 | $-1.7M | $-2.7M | ||
| Q4 24 | $-3.6M | $-827.0K | ||
| Q3 24 | $-3.5M | $4.0M | ||
| Q2 24 | $-4.3M | $4.2M | ||
| Q1 24 | $-7.1M | $-8.2M |
| Q4 25 | $-8.2M | $-2.4M | ||
| Q3 25 | $-906.0K | $2.3M | ||
| Q2 25 | $-1.7M | $3.1M | ||
| Q1 25 | $-1.7M | $-2.7M | ||
| Q4 24 | $-3.6M | $-1.1M | ||
| Q3 24 | $-3.5M | $3.6M | ||
| Q2 24 | $-4.3M | $4.2M | ||
| Q1 24 | $-7.2M | $-8.4M |
| Q4 25 | -134.4% | -47.9% | ||
| Q3 25 | -14.1% | 33.3% | ||
| Q2 25 | -27.6% | 42.2% | ||
| Q1 25 | -28.3% | -32.2% | ||
| Q4 24 | -66.1% | -8.6% | ||
| Q3 24 | -76.6% | 40.9% | ||
| Q2 24 | -92.0% | 45.8% | ||
| Q1 24 | -139.0% | -79.0% |
| Q4 25 | 4.9% | 3.2% | ||
| Q3 25 | 0.3% | 0.1% | ||
| Q2 25 | 0.3% | 0.4% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.1% | 2.3% | ||
| Q3 24 | 0.1% | 3.8% | ||
| Q2 24 | 0.7% | 0.0% | ||
| Q1 24 | 0.2% | 2.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.53× | ||
| Q3 24 | — | 3.25× | ||
| Q2 24 | -3.96× | 2.62× | ||
| Q1 24 | — | -3.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GSIT
| Distribution | $5.6M | 92% |
| Other | $459.0K | 8% |
SRTS
| Products | $2.8M | 57% |
| Other | $2.1M | 43% |
